Timothy P Coughlin - Net Worth and Insider Trading
Timothy P Coughlin Net Worth
The estimated net worth of Timothy P Coughlin is at least $17 Million dollars as of 2024-11-05. Timothy P Coughlin is the CFO of Neurocrine Biosciences Inc and owns about 137,961 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $17 Million. Timothy P Coughlin is the Director of aTyr Pharma Inc and owns about 56,000 shares of aTyr Pharma Inc (ATYR) stock worth over $176,400. Timothy P Coughlin is also the Director of Fate Therapeutics Inc and owns about 57,632 shares of Fate Therapeutics Inc (FATE) stock worth over $154,454. Details can be seen in Timothy P Coughlin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy P Coughlin has not made any transactions after 2024-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy P Coughlin
Timothy P Coughlin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy P Coughlin owns 4 companies in total, including Travere Therapeutics Inc (TVTX) , aTyr Pharma Inc (ATYR) , and Fate Therapeutics Inc (FATE) among others .
Click here to see the complete history of Timothy P Coughlin’s form 4 insider trades.
Insider Ownership Summary of Timothy P Coughlin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2015-03-31 | director |
| ATYR | aTyr Pharma Inc | 2024-05-30 | director |
| FATE | Fate Therapeutics Inc | 2022-06-03 | director |
 | | 2017-02-06 | VP and Chief Financial Officer |
Timothy P Coughlin Latest Holdings Summary
Timothy P Coughlin currently owns a total of 3 stocks. Among these stocks, Timothy P Coughlin owns 137,961 shares of Neurocrine Biosciences Inc (NBIX) as of February 6, 2017, with a value of $17 Million and a weighting of 98.06%. Timothy P Coughlin owns 56,000 shares of aTyr Pharma Inc (ATYR) as of May 30, 2024, with a value of $176,400 and a weighting of 1.03%. Timothy P Coughlin also owns 57,632 shares of Fate Therapeutics Inc (FATE) as of June 3, 2022, with a value of $154,454 and a weighting of 0.9%.
Latest Holdings of Timothy P Coughlin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences Inc | 2017-02-06 | 137,961 | 121.53 | 16,766,400 |
| ATYR | aTyr Pharma Inc | 2024-05-30 | 56,000 | 3.15 | 176,400 |
| FATE | Fate Therapeutics Inc | 2022-06-03 | 57,632 | 2.68 | 154,454 |
Holding Weightings of Timothy P Coughlin
Timothy P Coughlin Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 963 shares on February 6, 2017, which brought Timothy P Coughlin around $41,544.
According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 1 transactions in aTyr Pharma Inc (ATYR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in aTyr Pharma Inc is the acquisition of 50,000 shares on May 30, 2024, which cost Timothy P Coughlin around $87,500.
According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 1 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 1,439 shares on June 3, 2022, which brought Timothy P Coughlin around $32,824.
Insider Trading History of Timothy P Coughlin
- 1
Timothy P Coughlin Trading Performance
GuruFocus tracks the stock performance after each of Timothy P Coughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy P Coughlin is 14.22%. GuruFocus also compares Timothy P Coughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy P Coughlin within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy P Coughlin's insider trading performs compared to the benchmark.
Performance of Timothy P Coughlin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.67 | | | | | |
| Relative Return to S&P 500(%) | -16.16 | | | | | |
Timothy P Coughlin Ownership Network
Ownership Network List of Timothy P Coughlin
Ownership Network Relation of Timothy P Coughlin
Timothy P Coughlin Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Timothy P Coughlin is the director of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Medical Officer Jula Inrig , director & Chief Executive Officer Eric M Dube , and Chief Financial Officer Christopher R. Cline .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Timothy P Coughlin made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,823 shares made by Christopher R. Cline , a net sale of 9,089 shares made by William E. Rote , and a net sale of 9,089 shares made by Elizabeth E Reed .
In summary, during the past 3 months, insiders sold 117,969 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 117,969 shares. During the past 18 months, 150,147 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 150,147 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Timothy P Coughlin Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy P Coughlin. You might contact Timothy P Coughlin via mailing address: 339 North Granados Ave, Solana Beach Ca 92075.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
